Unveiling the Demographics and Clinical Characteristics of Diabetic Neuropathy: Findings From the National Health Insurance Service, 2012–2017
Journal of Diabetes · 2026-05 · 18 (5)
DOI: 10.1111/1753-0407.70196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes, online erschienen am 29.04.2026. Verfasst von Su Jin Jeong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Sejong General Hospital, Bucheon, Kyunggido, South Korea. Hauptthemen laut MEDLINE: Diabetic Neuropathies, National Health Programs, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Diabetic neuropathy (DN) is the most common chronic complication of Type 2 diabetes mellitus (T2DM), with reported prevalence ranging from 23% to 54.5%. This study evaluated the prevalence, clinical characteristics, and treatments of DN using Korean National Health Insurance Service (NHIS) data from 2012 to 2017.
Methods
We analyzed NHIS sample data for 8.7 million individuals stratified by age, sex, eligibility, and income. DN was defined using ICD‐10 codes (E10.4–E14.4, G59.0, G63.2, G99.0) and concurrent prescriptions for diabetes and DN. Annual DN prevalence among diabetes patients was calculated, and treatment patterns and patient characteristics were compared between those with and without DN.
Results
DN prevalence declined from 23.4% in 2012 to 21.5% in 2017. About half of DN patients received pharmacologic treatment—mainly monotherapy (up to 82%), followed by dual (15%) and triple therapy (3%). The most prescribed drugs were α‐lipoic acid (52.1%–55.0%), anticonvulsants (30.4%–34.5%), tricyclic antidepressants, SNRIs, and γ‐linolenic acid. DN patients were generally older, more often female, and had more comorbidities such as hypertension, dyslipidemia, cardiovascular disease, diabetic foot, and amputations. They were also more likely to use insulin or multiple oral agents.
Conclusion
About one‐quarter of patients with T2DM had DN, and half received treatment, mostly α ‐lipoic acid monotherapy. DN patients tended to be older and had multiple comorbidities, resulting in higher hospitalization rates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Sejong General Hospital, Bucheon, Kyunggido, South Korea.
- Department of Internal Medicine, Heartbeat Analysis Clinic, Sungnam, Kyunggido, South Korea.
ORCID-Profile: Su Jin Jeong, Chong Hwa Kim
Zitieren
APA
Jeong, S. J., Kim, S. K., & Kim, C. H. (2026). Unveiling the Demographics and Clinical Characteristics of Diabetic Neuropathy: Findings From the National Health Insurance Service, 2012–2017. Journal of Diabetes, 18(5). https://doi.org/10.1111/1753-0407.70196
Vancouver
Jeong SJ, Kim SK, Kim CH. Unveiling the Demographics and Clinical Characteristics of Diabetic Neuropathy: Findings From the National Health Insurance Service, 2012–2017. Journal of Diabetes. 2026;18(5). doi:10.1111/1753-0407.70196
BibTeX
@article{Jeong2026,
author = {Jeong, Su Jin and Kim, Sun Keun and Kim, Chong Hwa},
title = {Unveiling the Demographics and Clinical Characteristics of Diabetic Neuropathy: Findings From the National Health Insurance Service, 2012–2017},
journal = {Journal of Diabetes},
year = {2026},
volume = {18},
number = {5},
doi = {10.1111/1753-0407.70196}
}
EUVIMED